Corrigendum to “NAMPT regulates senescence, proliferation, and migration of endothelial progenitor cells through the SIRT1 AS lncRNA/miR-22/SIRT1 pathway” (NAMPT regulates senescence, proliferation, and migration of endothelial progenitor cells through the SIRT1 AS lncRNA/miR-22/SIRT1 pathway (2016) 478(3) (1382–1388), (S0006291X16313973), (10.1016/j.bbrc.2016.08.133));NAMPT regulates senescence, proliferation, and migration of endothelial progenitor cells through the SIRT1 AS lncRNA/miR-22/SIRT1 pathway

Biochemical and Biophysical Research Communications

Volumn 478, Issue 3, 2016, Pages 1382-1388

  Ming, Guang Feng ^a   Wu, Kai ^a   Hu, Kai ^a   Chen, Yao ^a   Xiao, Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells; lncRNA; miR 22; NAMPT; Senescence; SIRT1

Indexed keywords

ANTISENSE LONG NON CODING RNA; LONG UNTRANSLATED RNA; LUCIFERASE; MICRORNA 22; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RECOMBINANT ENZYME; RECOMBINANT NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; LONG NON-CODING RNA SIRT1 AS, MOUSE; MICRORNA; MIRN22 MICRORNA, MOUSE;

ANIMAL CELL; ARTICLE; CELL AGING; CELL MIGRATION; CELL PROLIFERATION; COMPETITIVE BINDING ASSAY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IN VITRO STUDY; LUCIFERASE ASSAY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL MOTION; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELLS; MICE; MICRORNAS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; SIRTUIN 1; UP-REGULATION;

EID: 84993939986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2020.02.111     Document Type: Erratum

References (32)

1. [1] Moran, A.E., Roth, G.A., Narula, J., Mensah, G.A., 1990-2010 global cardiovascular disease atlas. Glob. Heart 9 (2014), 3–16.
2. [2] Mudau, M., Genis, A., Lochner, A., Strijdom, H., Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J. Afr. 23 (2012), 222–231.
3. [3] Schmidt-Lucke, C., Rössig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kämper, U., Dimmeler, S., Zeiher, A.M., Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005), 2981–2987.
4. [4] George, J., Afek, A., Abashidze, A., Shmilovich, H., Deutsch, V., Kopolovich, J., Miller, H., Keren, G., Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2636–2641.
5. [5] Wang, P., Li, W.L., Liu, J.M., Miao, C.Y., NAMPT and NAMPT-controlled NAD metabolism in vascular repair. J. Cardiovasc Pharmacol. 67 (2016), 474–481.
6. [6] Kim, S.R., Bae, S.K., Choi, K.S., Park, S.Y., Jun, H.O., Lee, J.Y., Jang, H.O., Yun, I., Yoon, K.H., Kim, Y.J., Yoo, M.A., Kim, K.W., Bae, M.K., Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem. Biophys. Res. Commun. 357 (2007), 150–156.
7. [7] Xiao, J., Xiao, Z.J., Liu, Z.G., Gong, H.Y., Yuan, Q., Wang, S., Li, Y.J., Jiang, D.J., Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells. Diabetes Metab. Res. Rev. 25 (2009), 242–249.
8. [8] Revollo, J.R., Grimm, A.A., Imai, S., The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr. Opin. Gastroenterol. 23 (2007), 164–170.
9. [9] van der Veer, E., Ho, C., O'Neil, C., Barbosa, N., Scott, R., Cregan, S.P., Pickering, J.G., Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 282 (2007), 10841–10845.
10. [10] Balestrieri, M.L., Rienzo, M., Felice, F., Rossiello, R., Grimaldi, V., Milone, L., Casamassimi, A., Servillo, L., Farzati, B., Giovane, A., Napoli, C., High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim. Biophys. Acta 1784 (2008), 936–945.
11. [11] Ming, G.F., Tang, Y.J., Hu, K., Chen, Y., Huang, W.H., Xiao, J., Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway. Int. J. Mol. Med. 38 (2016), 643–649.
12. [12] Bhan, A., Mandal, S.S., Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem 9 (2014), 1932–1956.
13. [13] Uchida, S., Dimmeler, S., Long noncoding RNAs in cardiovascular diseases. Circ. Res. 116 (2015), 737–750.
14. [14] Leung, A., Natarajan, R., Noncoding RNAs in vascular disease. Curr. Opin. Cardiol. 29 (2014), 199–206.
15. [15] Wang, Y., Pang, W.J., Wei, N., Xiong, Y., Wu, W.J., Zhao, C.Z., Shen, Q.W., Yang, G.S., Identification, stability and expression of Sirt1 antisense long non-coding RNA. Gene 539 (2014), 117–124.
16. [16] Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D.G., Lagarde, J., Veeravalli, L., Ruan, X., Ruan, Y., Lassmann, T., Carninci, P., Brown, J.B., Lipovich, L., Gonzalez, J.M., Thomas, M., Davis, C.A., Shiekhattar, R., Gingeras, T.R., Hubbard, T.J., Notredame, C., Harrow, J., Guigó, R., The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22 (2012), 1775–1789.
17. [17] Yoon, J.H., Abdelmohsen, K., Gorospe, M., Functional interactions among microRNAs and long noncoding RNAs. Semin. Cell Dev. Biol. 34 (2014), 9–14.
18. [18] Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W.M., Silver, M., Kearney, M., Li, T., Isner, J.M., Asahara, T., Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 3422–3427.
19. [19] Hristov, M., Erl, W., Weber, P.C., Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23 (2003), 1185–1189.
20. [20] Liu, S.W., Qiao, S.B., Yuan, J.S., Liu, D.Q., Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Horm. Metab. Res. 41 (2009), 281–286.
21. [21] Kim, S.R., Bae, Y.H., Bae, S.K., Choi, K.S., Yoon, K.H., Koo, T.H., Jang, H.O., Yun, I., Kim, K.W., Kwon, Y.G., Yoo, M.A., Bae, M.K., Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim. Biophys. Acta 1783 (2008), 886–895.
22. [22] Lee, W.J., Wu, C.S., Lin, H., Lee, I.T., Wu, C.M., Tseng, J.J., Chou, M.M., Sheu, W.H., Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. Int. J. Obes. (Lond) 33 (2009), 465–472.
23. [23] Borradaile, N.M., Pickering, J.G., Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment. Aging Cell 8 (2009), 100–112.
24. [24] Lovren, F., Pan, Y., Shukla, P.C., Quan, A., Teoh, H., Szmitko, P.E., Peterson, M.D., Gupta, M., Al-Omran, M., Verma, S., Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E1440–E1449.
25. [25] Ota, H., Akishita, M., Eto, M., Iijima, K., Kaneki, M., Ouchi, Y., Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell Cardiol. 43 (2007), 571–579.
26. [26] Zhao, T., Li, J., Chen, A.F., MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 299 (2010), E110–E116.
27. [27] He, C., Ding, J.W., Li, S., Wu, H., Jiang, Y.R., Yang, W., Teng, L., Yang, J., The role of long intergenic noncoding RNA p21 in vascular endothelial cells. DNA Cell Biol. 34 (2015), 677–683.
28. [28] Wu, G., Cai, J., Han, Y., Chen, J., Huang, Z.P., Chen, C., Cai, Y., Huang, H., Yang, Y., Liu, Y., Xu, Z., He, D., Zhang, X., Hu, X., Pinello, L., Zhong, D., He, F., Yuan, G.C., Wang, D.Z., Zeng, C., LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130 (2014), 1452–1465.
29. [29] Tang, Y., Jin, X., Xiang, Y., Chen, Y., Shen, C.X., Zhang, Y.C., Li, Y.G., The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT. FEBS Lett. 589 (2015), 3189–3196.
30. [30] Ling, M.H., Ban, Y., Wen, H., Wang, S.M., Ge, S.X., Conserved expression of natural antisense transcripts in mammals. BMC Genomics, 14, 2013, 243.
31. [31] Chen, H., Lu, Q., Fei, X., Shen, L., Jiang, D., Dai, D., miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1. Tumour Biol. 37 (2016), 6761–6768.
32. [32] Xu, D., Takeshita, F., Hino, Y., Fukunaga, S., Kudo, Y., Tamaki, A., Matsunaga, J., Takahashi, R.U., Takata, T., Shimamoto, A., Ochiya, T., Tahara, H., miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193 (2011), 409–424.